Director, Global Health Economics Lead, Oncology Business Unit

About the role

Drive and realize value demonstration strategies for Takeda’s global oncology portfolio, achieving rapid, broad patient access and delivering differentiated, evidence-based pricing through best-in-class health technology assessment (HTA; including the EU Joint Clinical Assessment [JCA]) and payer decision outcomes. Lead cross-functional integration and impact, resulting in accelerated market access, measurable commercial performance, and sustainable advantage across various assets and indications worldwide.

Responsibilities

• Lead the strategic development, execution, and continuous optimization of global health economics (HE) plans, reimbursement strategy, and evidence communication.
• Build and deploy best-practice tools and training to maximize adoption and impact of global HE deliverables across all regions.
• Mobilize and align cross-functional and cross-regional stakeholders at all enterprise levels, including R&D, Market Access, and local operating companies (LOC), to ensure seamless integration of evidence requirements and accelerate value realization for patients and payers.
• Co-lead the vision, development, and adaptive evolution of enterprise-level frameworks (e.g., Integrated Evidence Generation Plans [EGPs]), ensuring that all evidence and access strategies are fully aligned with evolving payer, HTA, and policy needs globally.
• Pioneer and implement innovative digital, data science, and AI-driven health economics and outcomes research (HEOR) approaches, actively shaping Takeda’s future market access strategy. Influence enterprise-level decision-making and mentor emerging leaders through formal educational and strategic thought leadership programs.
• Advance Takeda’s global reputation and influence by proactively shaping thought leadership at international and industry forums, policy discussions, and leading scientific consortia—building strong partnerships with HTA, payer, academic and clinical stakeholders, and elevating Takeda’s position as a recognized leader in HE and value demonstration.

Qualifications

• Doctorate with 7+ years of experience, Master's with 9+ years of experience or Bachelor's with 12+ years of experience in healthcare industry with direct experience in global product value proposition development (industry or consulting) and interaction with payers, HTA bodies, relevant policymakers and strong patient-centered focus.
• Robust understanding of the global payer environment and in-depth understanding of ex-US payer landscape including HTA trends and guidance (e.g., NICE, CADTH, PBAC, EU JCA), along with knowledge of US Medicare (Part D), ICER in the US and trends in Emerging Markets (e.g., China) – including reimbursement methodologies, pricing/reimbursement authorities’ decision-making process and current reimbursement issues.
• Strong knowledge and hands on experience in health economics, health technology assessment (HTA) tools, methods and filings, SLRs, ITCs, statistical analyses and economic modelling.
• Strong knowledge and understanding of clinical and epidemiological information, innovative global pricing models, all phases of drug development methods of analysis of large databases (e.g., claims data, electronic health records) and the major areas of Outcomes Research (PROs, modelling).
• Leadership – strong ability to work in a highly matrixed organization.
• Strong analytical capabilities and excellent communication skills (written and oral).
• Strategic thinking and demonstrated problem solving capability.
• Influencing skills (one on one and in group setting) – consensus builder with ability to effectively drive decision making.
• Ability to translate technical issues to non-technical experts.

Preferred Qualifications

• Previous experience in Hematology and/or Oncology.
• A combination of in-depth knowledge of Global HTA (including EU JCA) requirements and direct experience in HTA submissions.
• Direct payer experience and/or experience in Market Access.
• Track record of peer-reviewed publications.